Signal transduction and targeted therapy.

ISSN 2095-9907Springer NatureUnited Kingdom
ScopusMEDLINEEmbasePubMedPMCSCImagoDOAJJIFMatched via identifier

Journal overview

Journal identity
Titles
Signal Transduction and Targeted Therapy
Signal Transduct. Target. Ther. (abbreviated)
Signal Transduct Target Ther (abbreviated)
Signal Transduction and Targeted Therapy SPRINGERNATURE
Signal transduction and targeted therapy.
Key identifiers
ISSN
2095-9907
2095-9907
eISSN
2059-3635
NLM ID
101676423
Publisher / basic metadata
Publisher
Springer Nature
Nature Publishing Group
[London] : Nature Publishing Group, [2016]-
Country
Language
English
ENG

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2016–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCCoverage available

Metrics

MetricYearValueQuartileRankSource
JIF202552.7Q122JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
17.74
Best Quartile
Q1
H-index
224
Subject categories
  • Cancer Research — Q1
  • Genetics — Q1
More metrics
Coverage
2016–2026
Country
United Kingdom
Region
Western Europe
Publisher
Springer Nature
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
423
Total documents (3 years)
1207
Total references
57802
Total citations (3 years)
58350
Citable documents (3 years)
843
Citations per document (2 years)
51.26
References per document
136.65
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
2059-3635, 2095-9907
SCImago Source ID
21100888816
SCImago Rank (across all SCImago source types)
25

Publication activity

Publication activity
SCImago
2025
423 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Open access

DOAJ — Directory of Open Access Journals

Source: DOAJ (Directory of Open Access Journals). Listing status and policy details are reported here as DOAJ published them.

Listed in DOAJ
Yes
License
CC BY, CC BY-NC-ND
APC (article processing charge)
3090 GBP; 4170 USD; 3390 EUR
More information
Waiver policy
Yes
Review process
Anonymous peer review
Plagiarism screening
Yes
Preservation services
CLOCKSS, Portico
Added to DOAJ
2016-11-29
Journal homepage
DOAJ profile
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2059-3635

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Molecular Targeted Therapy; Signal Transduction
Coverage / history
Scopus:2016-2026
MEDLINE:MEDLINE: v5, 2020-In: PubMed: v1, 2016-, PMC;
PubMed:MEDLINE: v5, 2020-In: PubMed: v1, 2016-, PMC;
PMC:v.1 2016 – v.11 2026